Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$490M |
| 2 |
Duke Energy
DUK
|
+$303M |
| 3 |
Gilead Sciences
GILD
|
+$164M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$159M |
| 5 |
Cisco
CSCO
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
KLA
KLAC
|
+$274M |
| 3 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$235M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$225M |
| 5 |
Microsoft
MSFT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.55% |
| 2 | Healthcare | 3.86% |
| 3 | Financials | 3.37% |
| 4 | Consumer Discretionary | 2.98% |
| 5 | Communication Services | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Urban Edge Properties
UE
$2.78B
| $223K | ﹤0.01% |
7,941
-52,071
| -87% | -$1.51M |
|
|
BNFT
3802
DELISTED
Benefitfocus, Inc.
BNFT
| $223K | ﹤0.01% |
5,581
-548
| -9% | -$22.5K |
|
|
PTHN
3803
DELISTED
Patheon N.V.
PTHN
| $223K | ﹤0.01% |
+7,539
| New | +$207K |
|
3804
PUT
BCE
BCE
$20.6B
| $222K | ﹤0.01% |
4,800
+3,500
| +269% | +$166K |
|
3805
Toro Company
TTC
$9.42B
| $222K | ﹤0.01% |
4,729
-4,251
| -47% | -$199K |
|
|
WPX
3806
PUT
DELISTED
WPX Energy, Inc.
WPX
| $222K | ﹤0.01% |
+16,800
| New | +$187K |
|
3807
ANI Pharmaceuticals
ANIP
$1.8B
| $221K | ﹤0.01% |
3,336
-17,931
| -84% | -$1.12M |
|
3808
Charles River Laboratories
CRL
$12.6B
| $221K | ﹤0.01% |
2,661
-12,736
| -83% | -$1.07M |
|
|
NGD
3809
CALL
DELISTED
New Gold Inc
NGD
| $221K | ﹤0.01% |
50,900
+2,000
| +4% | +$9.97K |
|
3810
Direxion Daily Technology Bull 3x ETF
TECL
$6.02B
| $221K | ﹤0.01% |
45,600
+17,200
| +61% | +$76.8K |
|
|
KERX
3811
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $221K | ﹤0.01% |
41,554
+2,717
| +7% | +$14.7K |
|
3812
PUT
Rambus
RMBS
$10.6B
| $220K | ﹤0.01% |
17,600
-14,200
| -45% | -$188K |
|
3813
Vanguard Information Technology ETF
VGT
$147B
| $220K | ﹤0.01% |
14,640
| – | – |
|
|
XCO
3814
DELISTED
Exco Resources
XCO
| $220K | ﹤0.01% |
13,804
+13,580
| +6,063% | +$243K |
|
|
ASCMA
3815
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $220K | ﹤0.01% |
9,510
-99
| -1% | -$1.98K |
|
3816
PUT
Clean Energy Fuels
CLNE
$414M
| $219K | ﹤0.01% |
48,900
+12,200
| +33% | +$46.6K |
|
3817
Lindblad Expeditions
LIND
$2.23B
| $219K | ﹤0.01% |
24,300
+845
| +4% | +$7.95K |
|
3818
Medpace
MEDP
$16.4B
| $219K | ﹤0.01% |
+7,328
| New | +$214K |
|
3819
CALL
Manitowoc
MTW
$512M
| $219K | ﹤0.01% |
11,450
+4,975
| +77% | +$100K |
|
3820
PUT
SAP
SAP
$228B
| $219K | ﹤0.01% |
2,400
-24,400
| -91% | -$2.1M |
|
|
NSM
3821
CALL
DELISTED
Nationstar Mortgage Holdings
NSM
| $219K | ﹤0.01% |
14,800
+11,800
| +393% | +$168K |
|
3822
Collegium Pharmaceutical
COLL
$1.16B
| $218K | ﹤0.01% |
11,308
+10,994
| +3,501% | +$131K |
|
3823
CALL
Equinor
EQNR
$90.6B
| $218K | ﹤0.01% |
13,000
-200
| -2% | -$3.25K |
|
3824
Prosperity Bancshares
PB
$8.94B
| $218K | ﹤0.01% |
3,995
+2,525
| +172% | +$134K |
|
3825
Oramed Pharmaceuticals
ORMP
$180M
| $217K | ﹤0.01% |
29,925
| – | – |
|
Similar funds
Barclays's Q3 2016 Portfolio in Review
As of Q3 2016, Barclays held 7,163 positions worth $90.1B, up 17% from $76.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $8.95B of net new capital in Q3 2016, opening 665 new positions and adding to 2,827 existing holdings. Its largest new stake was Dell: 9,434,097 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $593M trimmed.
- Barclays's largest Q3 2016 buy was Dell: 9,434,097 shares worth $127M.
- Barclays added most to Procter & Gamble in Q3 2016, an estimated $490M increase.
- Barclays's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $593M.
- Barclays fully exited EMC CORPORATION in Q3 2016, selling an estimated $225M.
- Barclays's ten largest holdings make up 36% of its $90.1B portfolio in Q3 2016.
- Barclays opened 665 new positions and closed 446 in Q3 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $90.1B.
Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.